PSF biotech collaboration on structure-based drug design with ALTANA Pharma AG
18 Aug 2005 -
PSF biotech announced that they have extended their pre-existing research collaboration in the field of structure-based drug design with ALTANA Pharma AG. PSF expresses ALTANA Pharma's target proteins and co-crystallizes them with ALTANA Pharma's own ligands. The structural elucidation of these proteins in complex with ligands allows for rapid optimization of active substances by computational approaches
and for design of new and innovative drugs. Financial terms of the agreement were not disclosed.
Top
Contact
Print version
PDF version
Send article
RSS feed
